← 產業報告目錄
Global Pharmaceutical Grade Potassium Chloride Market Research Report by Power Output [Intravenous Solutions (Electrolyte Replacement, Total Parenteral Nutrition, IV Fluids), Oral Medications (Tablets and Capsules, Liquid Solutions and Elixirs, Effervescent Tablets), Compounding, Hemodialysis], by Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies), by Region (North America, Europe, Asia-Pacific, Latin America, MEA) Forecast till 2035
授權報價
| Single User Price | $4,950 USD |
| Multi User Licence (up to 10 users) | $5,950 USD |
| Enterprisewide Price (Global Site License) | $7,250 USD |
報告摘要
Global Pharmaceutical Grade Potassium Chloride Market Research Report by Power Output [Intravenous Solutions (Electrolyte Replacement, Total Parenteral Nutrition, IV Fluids), Oral Medications (Tablets and Capsules, Liquid Solutions and Elixirs, Effervescent Tablets), Compounding, Hemodialysis], by Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies), by Region (North America, Europe, Asia-Pacific, Latin America, MEA) Forecast till 2035
Market Overview
In 2024, Global Pharmaceutical Grade Potassium Chloride Market is valued at USD 172.58 million, with an expected CAGR of 6.3% from 2024 to 2032, indicating steady growth.
Global Pharmaceutical Grade Potassium Chloride Market is witnessing steady growth due to several key drivers. The increasing prevalence of chronic diseases such as hypertension, kidney disorders, and cardiovascular conditions has heightened the demand for effective electrolyte replacement therapies. Additionally, the rising global geriatric population, more prone to such health issues, further contributes to the expanding need for potassium chloride in intravenous and oral formulations. Growth in healthcare infrastructure, especially in emerging economies, is improving access to essential medical treatments, including potassium supplementation. Regulatory approvals and the establishment of clinical guidelines have also facilitated the safe and standardized use of pharmaceutical-grade potassium chloride across regions.
However, the market faces certain restraints. Strict regulatory requirements across different countries can delay product approvals and increase compliance costs. Moreover, fluctuations in raw material prices and competition from alternative therapies, such as oral rehydration salts or other electrolyte solutions, pose challenges to consistent market growth. There is also limited awareness among healthcare providers about newer potassium chloride formulations.
Nonetheless, promising opportunities are emerging. The rise of personalized medicine and advancements in drug delivery technologies are opening new application areas. The growing focus on fitness and sports health, along with the expansion of telehealth and remote monitoring services, is further driving demand for portable and accessible electrolyte therapies.
Market Segmentation
Global pharmaceutical grade Potassium Chloride market has been segmented by the power output, includes intravenous solutions, oral medications, compounding, hemodialysis. Electrolyte replacement, total parenteral nutrition, IV fluids are parts of intravenous solutions. Conversely, tablets and capsules, liquid solutions and elixirs, effervescent tablets are under the oral medications.
Global pharmaceutical grade potassium chloride market is categorized by distribution channels, which include hospital-based pharmacies, retail drugstores, and online pharmacy platforms.
Depends on the regional type, global pharmaceutical grade Potassium Chloride includes North America, Latin America, Asia-Pacific, Middle East Africa, Europe.
Regional Insights
In North America, the pharmaceutical-grade potassium chloride market continues to grow steadily, supported by an advanced healthcare system and stringent pharmaceutical manufacturing regulations. The region’s aging population and the increasing incidence of chronic illnesses have heightened the demand for electrolyte therapy, further boosting market expansion.
In Europe, the market remains stable and well-supported by a strong pharmaceutical industry and strict regulatory protocols that ensure the safety and efficacy of pharmaceutical ingredients. The use of high-purity potassium chloride is essential in intravenous treatments and electrolyte therapy, contributing to consistent demand across the region.
The Asia-Pacific region is seeing significant growth in this market segment, primarily due to ongoing developments in healthcare infrastructure and the rapid growth of pharmaceutical manufacturing. Nations like China, India, Japan, and South Korea are leading this progress through investments in R&D and the adoption of advanced technologies that deliver high-purity formulations suitable for pharmaceutical use.
In South America, the market for pharmaceutical-grade potassium chloride is expanding at a moderate pace. The increasing need for electrolyte replacement therapies, especially in treating potassium deficiencies like hypokalemia, is a key factor. Regulatory agencies such as Brazil’s ANVISA and Mexico’s COFEPRIS ensure compliance with global pharmaceutical quality standards.
In the Middle East and Africa (MEA) region, market growth is gradual but promising. The expansion is largely fueled by ongoing enhancements in healthcare services and increased investment from both governmental and private sectors aimed at developing the regional pharmaceutical industry.
Major Players
Lianyungang Zhonghong Chemical Co, Ltd., Takasugi Pharmaceutical Co. Ltd., K+S Aktiengesellschaft, ICL Group Ltd, ITW Reagents, Foodchem International Corporation, Arch Industries, Morton Salt Inc, Stanford Chemicals, are key companies of global pharmaceutical grade potassium chloride market.
目錄 Table of Contents
TABLE OF CONTENTS
1 EXECUTIVE SUMMARY ................................................................................................................. 16
1.1 MARKET OVERVIEW: ............................................................................................................................................... 17
1.2 MARKET SEGMENTATION ..................................................................................................................................... 17
1.3 COMPETITIVE LANDSCAPE .................................................................................................................................... 17
1.4 FUTURE OUTLOOK ..................................................................................................................................................... 18
2 MARKET INTRODUCTION ............................................................................................................. 20
2.1 DEFINITION .................................................................................................................................................................. 20
2.2 SCOPE OF THE STUDY .............................................................................................................................................. 20
2.3 RESEARCH OBJECTIVE ............................................................................................................................................ 20
2.4 MARKET STRUCTURE .............................................................................................................................................. 21
3 RESEARCH METHODOLOGY ........................................................................................................ 22
3.1 OVERVIEW .................................................................................................................................................................... 22
3.2 DATA FLOW .................................................................................................................................................................. 24
3.2.1 DATA MINING PROCESS ....................................................................................................................................... 24
3.3 PURCHASED DATABASE: ......................................................................................................................................... 25
3.4 SECONDARY SOURCES: ............................................................................................................................................ 26
3.4.1 SECONDARY RESEARCH DATA FLOW: ....................................................................................................................... 27
3.5 PRIMARY RESEARCH: ............................................................................................................................................... 28
3.5.1 PRIMARY RESEARCH DATA FLOW: ....................................................................................................................... 29
3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED ......................................................................................... 30
3.5.3 PRIMARY RESEARCH: REGIONAL COVERAGE .............................................................................................................. 30
3.6 APPROACHES FOR MARKET END USER ESTIMATION: ............................................................................... 31
3.6.1 REVENUE ANALYSIS APPROACH ............................................................................................................................ 31
3.6.2 DATA FORECASTING ............................................................................................................................................. 32
3.6.3 DATA FORECASTING TECHNIQUE ............................................................................................................................ 32
3.7 DATA MODELING ........................................................................................................................................................ 33
3.7.1 MICROECONOMIC FACTOR ANALYSIS: ....................................................................................................................... 33
3.7.2 DATA MODELING: ............................................................................................................................................... 34
3.8 TEAMS AND ANALYST CONTRIBUTION ........................................................................................................... 35
4 MARKET DYNAMICS ...................................................................................................................... 37
4.1 INTRODUCTION ........................................................................................................................................................... 37
4.2 DRIVERS ......................................................................................................................................................................... 38
4.2.1 INCREASING PREVALENCE OF CHRONIC DISEASES ....................................................................................................... 38
4.2.2 RISING DEMAND FOR ELECTROLYTE REPLACEMENT THERAPIES ........................................................................................ 38
4.2.3 GROWTH IN THE GLOBAL GERIATRIC POPULATION .......................................................................................................... 38
4.2.4 EXPANSION OF HEALTHCARE INFRASTRUCTURE ............................................................................................................ 38
4.2.5 REGULATORY APPROVALS AND GUIDELINES FOR POTASSIUM CHLORIDE USE ....................................................................... 39
4.3 RESTRAINTS ................................................................................................................................................................ 40
4.3.1 STRINGENT REGULATORY REQUIREMENTS ................................................................................................................... 40
4.3.2 PRICE VOLATILITY OF RAW MATERIALS ....................................................................................................................... 40
4.3.3 COMPETITION FROM ALTERNATIVE THERAPIES ............................................................................................................ 40
4.3.4 LIMITED AWARENESS AMONG HEALTHCARE PROFESSIONALS......................................................................................... 40
4.4 OPPORTUNITY ............................................................................................................................................................. 42
4.4.1 EMERGENCE OF PERSONALIZED MEDICINE APPROACHES ............................................................................................ 42
4.4.2 ADVANCEMENTS IN DRUG FORMULATION TECHNOLOGIES .............................................................................................. 42
4.4.3 INCREASE IN GLOBAL SPORTS AND FITNESS TRENDS ..................................................................................................... 42
4.4.4 EXPANSION OF TELEHEALTH SERVICES AND REMOTE PATIENT MONITORING ....................................................................... 42
4.5 IMPACT ANALYSIS OF COVID – 19 ....................................................................................................................... 43
4.5.1 IMPACT OF COVID ON GLOBAL PHARMACEUTICAL GRADE POTASSIUM CHLORIDE (KCL) MARKET ............................................ 43
4.5.2 IMPACT ON SUPPLY CHAIN OF PHARMACEUTICAL GRADE POTASSIUM CHLORIDE (KCL) MARKET ........................................... 43
4.5.3 IMPACT ON MARKET DEMAND OF PHARMACEUTICAL GRADE POTASSIUM CHLORIDE (KCL) MARKET ....................................... 43
5 MARKET FACTOR ANALYSIS ........................................................................................................ 44
5.1 SUPPLY CHAIN ANALYSIS ..................................................................................................................................... 44
5.1.1 RAW MATERIAL SOURCING AND PRODUCTION............................................................................................................. 45
5.1.2 TRANSPORTATION AND DISTRIBUTION ....................................................................................................................... 45
5.1.3 END-USE APPLICATIONS ...................................................................................................................................... 45
5.2 PORTER’S FIVE FORCES MODEL ........................................................................................................................... 46
5.2.1 THREAT OF NEW ENTRANTS ................................................................................................................................... 47
5.2.2 BARGAINING POWER OF SUPPLIERS ......................................................................................................................... 47
5.2.3 THREAT OF SUBSTITUTES ...................................................................................................................................... 47
5.2.4 BARGAINING POWER OF BUYERS ............................................................................................................................ 47
5.2.5 INTENSITY OF RIVALRY .......................................................................................................................................... 47
6 GLOBAL PHARMACEUTICAL GRADE POTASSIUM CHLORIDE MARKET, BY APPLICATION 49
6.1 INTRODUCTION ........................................................................................................................................................... 49
6.2 INTRAVENOUS (IV) SOLUTIONS ........................................................................................................................... 51
6.3 ORAL MEDICATIONS ................................................................................................................................................. 51
6.4 COMPOUNDING ........................................................................................................................................................... 51
6.5 HEMODIALYSIS ........................................................................................................................................................... 51
7 GLOBAL PHARMACEUTICAL GRADE POTASSIUM CHLORIDE MARKET, BY DISTRIBUTION
CHANNEL .............................................................................................................................................. 52
7.1 INTRODUCTION ........................................................................................................................................................... 52
7.2 HOSPITAL PHARMACIES ......................................................................................................................................... 53
7.3 RETAIL PHARMACIES .............................................................................................................................................. 53
7.4 ONLINE PHARMACIES .............................................................................................................................................. 53
8 GLOBAL PHARMACEUTICAL GRADE POTASSIUM CHLORIDE MARKET, BY REGION ........... 54
8.1 OVERVIEW .................................................................................................................................................................... 54
8.2 NORTH AMERICA ....................................................................................................................................................... 55
8.2.1 USA ............................................................................................................................................................... 58
8.2.2 CANADA ........................................................................................................................................................ 59
8.3 EUROPE .......................................................................................................................................................................... 60
8.3.1 UNITED KINGDOM............................................................................................................................................... 63
8.3.2 GERMANY ......................................................................................................................................................... 64
8.3.3 FRANCE ............................................................................................................................................................ 65
8.3.4 RUSSIA ............................................................................................................................................................ 66
8.3.5 ITALY ............................................................................................................................................................... 67
8.3.6 SPAIN ............................................................................................................................................................. 68
8.3.7 REST OF EUROPE ................................................................................................................................................. 69
8.4 ASIA PACIFIC ............................................................................................................................................................... 70
8.4.1 CHINA.............................................................................................................................................................. 73
8.4.2 JAPAN ............................................................................................................................................................. 74
8.4.3 INDIA .............................................................................................................................................................. 75
8.4.4 SOUTH KOREA .................................................................................................................................................... 76
8.4.5 MALAYSIA ........................................................................................................................................................ 77
8.4.6 THAILAND .......................................................................................................................................................... 78
8.4.7 REST OF APAC .................................................................................................................................................... 79
8.5 SOUTH AMERICA ....................................................................................................................................................... 80
8.5.1 BRAZIL ............................................................................................................................................................. 83
8.5.2 MEXICO ........................................................................................................................................................... 84
8.5.3 ARGENTINA........................................................................................................................................................ 85
8.5.4 REST OF SOUTH AMERICA ...................................................................................................................................... 86
8.6 MIDDEL EAST AND AFRICA .................................................................................................................................... 87
8.6.1 GCC COUNTRIES ................................................................................................................................................. 90
8.6.2 SOUTH AFRICA .................................................................................................................................................... 91
8.6.3 REST OF MEA ..................................................................................................................................................... 92
9 COMPETITIVE LANDSCAPE .......................................................................................................... 93
9.1 INTRODUCTION ........................................................................................................................................................... 93
9.2 MARKET SHARE ANALYSIS, 2024 ....................................................................................................................... 93
9.3 COMPETITOR DASHBOARD..................................................................................................................................... 94
9.4 KEY DEVELOPMENTS & GROWTH STRATEGIES ............................................................................................ 95
9.4.1 KEY DEVELOPMENT ............................................................................................................................................ 95
10 COMPANY PROFILES .................................................................................................................... 96
10.1 ICL GROUP LTD ............................................................................................................................................................ 96
10.1.1 COMPANY OVERVIEW ..................................................................................................................................... 96
10.1.2 PRODUCT OFFERED ............................................................................................................................................ 97
10.1.3 SWOT ANALYSIS ............................................................................................................................................ 97
10.1.4 FINANCIAL ANALYSIS ............................................................................................................................................ 98
10.1.5 KEY STRATEGY ................................................................................................................................................... 98
10.2 K+S AKTIENGESELLSCHAFT ................................................................................................................................. 99
10.2.1 COMPANY OVERVIEW ..................................................................................................................................... 99
10.2.2 PRODUCT OFFERED ........................................................................................................................................ 99
10.2.3 SWOT ANALYSIS ............................................................................................................................................ 100
10.2.4 FINANCIAL ANALYSIS ............................................................................................................................................ 101
10.2.5 KEY STRATEGY ................................................................................................................................................... 101
10.3 ITW REAGENTS .......................................................................................................................................................... 102
10.3.1 COMPANY OVERVIEW ..................................................................................................................................... 102
10.3.2 PRODUCT OFFERED ............................................................................................................................................ 102
10.3.3 SWOT ANALYSIS ............................................................................................................................................ 103
10.3.4 KEY STRATEGY ................................................................................................................................................... 103
10.4 FOODCHEM INTERNATIONAL CORPORATION ................................................................................................ 104
10.4.1 COMPANY OVERVIEW ..................................................................................................................................... 104
10.4.2 PRODUCTS OFFERED ...................................................................................................................................... 104
10.4.3 SWOT ANALYSIS ............................................................................................................................................ 105
10.4.4 KEY STRATEGY ................................................................................................................................................... 105
10.5 ARCH INDUSTRIES ..................................................................................................................................................... 106
10.5.1 COMPANY OVERVIEW ..................................................................................................................................... 106
10.5.2 PRODUCT OFFERED ............................................................................................................................................ 106
10.5.3 SWOT ANALYSIS ............................................................................................................................................ 107
10.5.4 KEY STRATEGY ................................................................................................................................................... 107
10.6 LIANYUNGANG ZHONGHONG CHEMICAL CO., LTD. ...................................................................................... 108
10.6.1 COMPANY OVERVIEW ..................................................................................................................................... 108
10.6.2 PRODUCT OFFERED ............................................................................................................................................ 108
10.6.3 SWOT ANALYSIS ............................................................................................................................................ 109
10.6.4 KEY STRATEGY ................................................................................................................................................... 109
10.7 TAKASUGI PHARMACEUTICAL CO., LTD. .......................................................................................................... 110
10.7.1 COMPANY OVERVIEW ..................................................................................................................................... 110
10.7.2 PRODUTS OFFERED ........................................................................................................................................ 110
10.7.3 SWOT ANALYSIS ............................................................................................................................................ 111
10.7.4 KEY STRATEGY ................................................................................................................................................... 111
10.8 MORTON SALT, INC. .................................................................................................................................................. 112
10.8.1 COMPANY OVERVIEW ..................................................................................................................................... 112
10.8.2 PRODUCT OFFERED ............................................................................................................................................ 112
10.8.3 SWOT ANALYSIS ............................................................................................................................................ 113
10.8.4 KEY STRATEGY ................................................................................................................................................... 113
10.9 STANFORD CHEMICALS COMPANY .................................................................................................................... 114
10.9.1 COMPANY OVERVIEW ..................................................................................................................................... 114
10.9.2 PRODUCT OFFERED ............................................................................................................................................ 115
10.9.3 SWOT ANALYSIS ............................................................................................................................................ 115
圖表清單 List of Tables & Figures
LIST OF TABLES
TABLE 1 GLOBAL PHARMACEUTICAL GRADE POTASSIUM CHLORIDE MARKET, BY APPLICATION, 2019-2035 (USD THOUSAND) 50
TABLE 2 GLOBAL PHARMACEUTICAL GRADE POTASSIUM CHLORIDE MARKET, DISTRIBUTION CHANNEL, 2019-2035 (USD THOUSAND) 52
TABLE 3 GLOBAL PHARMACEUTICAL GRADE POTASSIUM CHLORIDE MARKET, BY REGION, 2019-2035 (USD THOUSAND) 54
TABLE 4 NORTH AMERICA: PHARMACEUTICAL GRADE POTASSIUM CHLORIDE MARKET, BY COUNTRY, 2019-2035 (USD THOUSAND) 57
TABLE 5 NORTH AMERICA PHARMACEUTICAL GRADE POTASSIUM CHLORIDE MARKET, BY APPLICATION, 2019-2035 (USD THOUSAND) 57
TABLE 6 NORTH AMERICA PHARMACEUTICAL GRADE POTASSIUM CHLORIDE MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD THOUSAND) 58
TABLE 7 USA PHARMACEUTICAL GRADE POTASSIUM CHLORIDE MARKET, BY APPLICATION, 2019-2035 (USD THOUSAND) 58
TABLE 8 SA PHARMACEUTICAL GRADE POTASSIUM CHLORIDE MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD THOUSAND) 59
TABLE 9 CANADA PHARMACEUTICAL GRADE POTASSIUM CHLORIDE MARKET, BY APPLICATION, 2019-2035 (USD THOUSAND) 59
TABLE 10 CANADA PHARMACEUTICAL GRADE POTASSIUM CHLORIDE MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD THOUSAND) 59
TABLE 11 EUROPE: PHARMA GRADE KCL MARKET, BY COUNTRY, 2019-2035 (USD THOUSAND) 61
TABLE 12 EUROPE PHARMACEUTICAL GRADE POTASSIUM CHLORIDE MARKET, BY APPLICATION, 2019-2035 (USD THOUSAND) 62
TABLE 13 EUROPE PHARMACEUTICAL GRADE POTASSIUM CHLORIDE MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD THOUSAND) 62
TABLE 14 UK PHARMACEUTICAL GRADE POTASSIUM CHLORIDE MARKET, BY APPLICATION, 2019-2035 (USD THOUSAND) 63
TABLE 15 UK PHARMACEUTICAL GRADE POTASSIUM CHLORIDE MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD THOUSAND) 63
TABLE 16 GERMANY PHARMACEUTICAL GRADE POTASSIUM CHLORIDE MARKET, BY APPLICATION, 2019-2035 (USD THOUSAND) 64
TABLE 17 GERMANY PHARMACEUTICAL GRADE POTASSIUM CHLORIDE MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD THOUSAND) 64
TABLE 18 FRANCE PHARMACEUTICAL GRADE POTASSIUM CHLORIDE MARKET, BY APPLICATION, 2019-2035 (USD THOUSAND) 65
TABLE 19 FRANCE PHARMACEUTICAL GRADE POTASSIUM CHLORIDE MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD THOUSAND) 65
TABLE 20 RUSSIA PHARMACEUTICAL GRADE POTASSIUM CHLORIDE MARKET, BY APPLICATION, 2019-2035 (USD THOUSAND) 66
TABLE 21 RUSSIA PHARMACEUTICAL GRADE POTASSIUM CHLORIDE MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD THOUSAND) 66
TABLE 22 ITALY PHARMACEUTICAL GRADE POTASSIUM CHLORIDE MARKET, BY APPLICATION, 2019-2035 (USD THOUSAND) 67
TABLE 23 ITALY PHARMACEUTICAL GRADE POTASSIUM CHLORIDE MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD THOUSAND) 67
TABLE 24 SPAIN PHARMACEUTICAL GRADE POTASSIUM CHLORIDE MARKET, BY APPLICATION, 2019-2035 (USD THOUSAND) 68
TABLE 25 SPAIN PHARMACEUTICAL GRADE POTASSIUM CHLORIDE MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD THOUSAND) 68
TABLE 26 ROE PHARMACEUTICAL GRADE POTASSIUM CHLORIDE MARKET, BY APPLICATION, 2019-2035 (USD THOUSAND) 69
TABLE 27 ROE PHARMACEUTICAL GRADE POTASSIUM CHLORIDE MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD THOUSAND) 69
TABLE 28 APAC PHARMACEUTICAL GRADE POTASSIUM CHLORIDE MARKET, BY APPLICATION, 2019-2035 (USD THOUSAND) 72
TABLE 29 APAC PHARMACEUTICAL GRADE POTASSIUM CHLORIDE MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD THOUSAND) 72
TABLE 30 CHINA PHARMACEUTICAL GRADE POTASSIUM CHLORIDE MARKET, BY APPLICATION, 2019-2035 (USD THOUSAND) 73
TABLE 31 CHINA PHARMACEUTICAL GRADE POTASSIUM CHLORIDE MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD THOUSAND) 73
TABLE 32 JAPAN PHARMACEUTICAL GRADE POTASSIUM CHLORIDE MARKET, BY APPLICATION, 2019-2035 (USD THOUSAND) 74
TABLE 33 JAPAN PHARMACEUTICAL GRADE POTASSIUM CHLORIDE MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD THOUSAND) 74
TABLE 34 INDIA PHARMACEUTICAL GRADE POTASSIUM CHLORIDE MARKET, BY APPLICATION, 2019-2035 (USD THOUSAND) 75
TABLE 35 INDIA PHARMACEUTICAL GRADE POTASSIUM CHLORIDE MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD THOUSAND) 75
TABLE 36 SOUTH KOREA PHARMACEUTICAL GRADE POTASSIUM CHLORIDE MARKET, BY APPLICATION, 2019-2035 (USD THOUSAND) 76
TABLE 37 SOUTH KOREA PHARMACEUTICAL GRADE POTASSIUM CHLORIDE MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD THOUSAND) 76
TABLE 38 MALAYSIA PHARMACEUTICAL GRADE POTASSIUM CHLORIDE MARKET, BY APPLICATION, 2019-2035 (USD THOUSAND) 77
TABLE 39 MALAYSIA PHARMACEUTICAL GRADE POTASSIUM CHLORIDE MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD THOUSAND) 77
TABLE 40 THAILAND PHARMACEUTICAL GRADE POTASSIUM CHLORIDE MARKET, BY APPLICATION, 2019-2035 (USD THOUSAND) 78
TABLE 41 THAILAND PHARMACEUTICAL GRADE POTASSIUM CHLORIDE MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD THOUSAND) 78
TABLE 42 REST OF APAC PHARMACEUTICAL GRADE POTASSIUM CHLORIDE MARKET, BY APPLICATION, 2019-2035 (USD THOUSAND) 79
TABLE 43 REST OF APAC PHARMACEUTICAL GRADE POTASSIUM CHLORIDE MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD THOUSAND) 79
TABLE 44 SOUTH AMERICA PHARMACEUTICAL GRADE POTASSIUM CHLORIDE MARKET, BY APPLICATION, 2019-2035 (USD THOUSAND) 82
TABLE 45 SOUTH AMERICA PHARMACEUTICAL GRADE POTASSIUM CHLORIDE MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD THOUSAND) 82
TABLE 46 BRAZIL PHARMACEUTICAL GRADE POTASSIUM CHLORIDE MARKET, BY APPLICATION, 2019-2035 (USD THOUSAND) 83
TABLE 47 BRAZIL PHARMACEUTICAL GRADE POTASSIUM CHLORIDE MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD THOUSAND) 83
TABLE 48 MEXICO PHARMACEUTICAL GRADE POTASSIUM CHLORIDE MARKET, BY APPLICATION, 2019-2035 (USD THOUSAND) 84
TABLE 49 MEXICO PHARMACEUTICAL GRADE POTASSIUM CHLORIDE MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD THOUSAND) 84
TABLE 50 ARGENTINA PHARMACEUTICAL GRADE POTASSIUM CHLORIDE MARKET, BY APPLICATION, 2019-2035 (USD THOUSAND) 85
TABLE 51 ARGENTINA PHARMACEUTICAL GRADE POTASSIUM CHLORIDE MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD THOUSAND) 85
TABLE 52 REST OF SA PHARMACEUTICAL GRADE POTASSIUM CHLORIDE MARKET, BY APPLICATION, 2019-2035 (USD THOUSAND) 86
TABLE 53 REST OF SA PHARMACEUTICAL GRADE POTASSIUM CHLORIDE MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD THOUSAND) 86
TABLE 54 MIDDEL EAST AND AFRICA PHARMA GRADE KCL MARKET, BY COUNTRY, 2019-2035 (USD THOUSAND) 88
TABLE 55 MEA PHARMACEUTICAL GRADE POTASSIUM CHLORIDE MARKET, BY APPLICATION, 2019-2035 (USD THOUSAND) 89
TABLE 56 MEA PHARMACEUTICAL GRADE POTASSIUM CHLORIDE MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD THOUSAND) 89
TABLE 57 GCC PHARMACEUTICAL GRADE POTASSIUM CHLORIDE MARKET, BY APPLICATION, 2019-2035 (USD THOUSAND) 90
TABLE 58 GCC PHARMACEUTICAL GRADE POTASSIUM CHLORIDE MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD THOUSAND) 90
TABLE 59 SOUTH AFRICA PHARMACEUTICAL GRADE POTASSIUM CHLORIDE MARKET, BY APPLICATION, 2019-2035 (USD THOUSAND) 91
TABLE 60 SOUTH AFRICA PHARMACEUTICAL GRADE POTASSIUM CHLORIDE MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD THOUSAND) 91
TABLE 61 REST OF MEA PHARMACEUTICAL GRADE POTASSIUM CHLORIDE MARKET, BY APPLICATION, 2019-2035 (USD THOUSAND) 92
TABLE 62 REST OF MEA PHARMACEUTICAL GRADE POTASSIUM CHLORIDE MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD THOUSAND) 92
TABLE 63 KEY DEVELOPMENT 95
TABLE 64 ICL GROUP: TYPES OFFERED 97
TABLE 65 K+S AKTIENGESELLSCHAFT: PRODUCT OFFERED 99
TABLE 66 ITW REAGENTS: PRODUCT OFFERED 102
TABLE 67 FOODCHEM INTERNATIONAL CORPORATION: PRODUTS OFFERED 104
TABLE 68 ARCH INDUSTRIES: TYPES OFFERED 106
TABLE 69 LIANYUNGANG ZHONGHONG CHEMICAL CO., LTD.: TYPES OFFERED 108
TABLE 70 TAKASUGI PHARMACEUTICAL CO., LTD.: PRODUTS OFFERED 110
TABLE 71 MORTON SALT, INC.: TYPES OFFERED 112
TABLE 72 STANFORD CHEMICALS COMPANY: TYPES OFFERED115
LIST OF FIGURES
FIGURE 1 GLOBAL PHARMA GRADE POTASSIUM CHLORIDE MARKET SEGMENT 21
FIGURE 2 GLOBAL PHARMA GRADE POTASSIUM CHLORIDE MARKET: GROWTH FACTOR ANALYSIS (2023-2032) 37
FIGURE 3 DRIVER IMPACT ANALYSIS (2023-2032) 39
FIGURE 5 RESTRAINT IMPACT ANALYSIS (2023-2032) 41
FIGURE 6 SUPPLY CHAIN ANALYSIS: GLOBAL PHARMA GRADE KCL MARKET 44
FIGURE 7 PORTER’S FIVE FORCES MODEL: GLOBAL PHARMA GRADE KCL MARKET 46
FIGURE 8 GLOBAL PHARMACEUTICAL GRADE POTASSIUM CHLORIDE MARKET, BY APPLICATION, SEGMENT ATTRACTIVENESS ANALYSIS
49
FIGURE 9 GLOBAL PHARMACEUTICAL GRADE POTASSIUM CHLORIDE MARKET, BY APPLICATION, 2024 (% SHARE) 50
FIGURE 10 GLOBAL PHARMACEUTICAL GRADE POTASSIUM CHLORIDE MARKET, BY DISTRIBUTION CHANNEL, SEGMENT ATTRACTIVENESS
ANALYSIS 52
FIGURE 11 GLOBAL PHARMACEUTICAL GRADE POTASSIUM CHLORIDE MARKET, BY DISTRIBUTION CHANNEL, 2024 (% SHARE) 53
FIGURE 12 GLOBAL PHARMACEUTICAL GRADE POTASSIUM CHLORIDE MARKET, BY REGION, 2024 (% SHARE) 55
FIGURE 13 NORTH AMERICAN MARKET: SWOT ANALYSIS 56
FIGURE 14 NORTH AMERICA: PHARMACEUTICAL GRADE POTASSIUM CHLORIDE MARKET SHARE, BY COUNTRY, 2024 (% SHARE) 56
FIGURE 15 EUROPE MARKET: SWOT ANALYSIS 60
FIGURE 16 EUROPE: PHARMA GRADE KCL MARKET SHARE, BY COUNTRY, 2024 (% SHARE) 61
FIGURE 17 ASIA PACIFIC MARKET: SWOT ANALYSIS 70
FIGURE 18 ASIA PACIFIC: PHARMA GRADE KCL MARKET SHARE, BY COUNTRY, 2024 (% SHARE) 71
FIGURE 19 SOUTH AMERICA MARKET: SWOT ANALYSIS 80
FIGURE 20 SOUTH AMERICA: PHARMA GRADE POTASSIUM CHLORIDE MARKET SHARE, BY COUNTRY, 2024 (% SHARE) 81
FIGURE 21 MIDDEL EAST AND AFRICA: SWOT ANALYSIS 87
FIGURE 22 MIDDEL EAST AND AFRICA: PHARMA GRADE KCL MARKET SHARE, BY COUNTRY, 2024 (% SHARE) 88
FIGURE 23 GLOBAL PHARMACEUTICAL GRADE POTASSIUM CHLORIDE MARKET: COMPETITIVE ANALSIS, 2024 93
FIGURE 24 COMPETITOR DASHBOARD: GLOBAL PHARMACEUTICAL GRADE POTASSIUM CHLORIDE MARKET 94
FIGURE 25 EATON: SWOT ANALYSIS 97
FIGURE 26 K+S AKTIENGESELLSCHAFT: SWOT ANALYSIS 100
FIGURE 27 ITW REAGENTS: SWOT ANALYSIS 103
FIGURE 28 FOODCHEM INTERNATIONAL CORPORATION: SWOT ANALYSIS 105
FIGURE 29 ARCH INDUSTRIES: SWOT ANALYSIS 107
FIGURE 30 LIANYUNGANG ZHONGHONG CHEMICAL CO., LTD.: SWOT ANALYSIS 109
FIGURE 31 TAKASUGI PHARMACEUTICAL CO., LTD: SWOT ANALYSIS 111
FIGURE 32 MORTON SALT, INC.: SWOT ANALYSIS 113
FIGURE 33 STANFORD CHEMICALS COMPANY: SWOT ANALYSIS 115
提及公司
K+S AktiengesellschaftICL Group LtdITW ReagentsFoodchem International CorporationArch IndustriesLianyungang Zhonghong Chemical CoLtd.Takasugi Pharmaceutical Co. Ltd.Morton Salt IncStanford Chemicals
同分類最新報告（化學與材料）
查看化學與材料全部報告 →
量子訊息有限公司為 Market Research Future 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們